Meeting News

DCB shows durable real-world effectiveness at 4 years

November 12, 2019
LAS VEGAS — In a real-world population with peripheral artery disease, nearly three-quarters of patients treated with a drug-coated balloon…

Meeting News

Ascertainment bias could explain paclitaxel mortality signal

November 11, 2019
LAS VEGAS — It is possible that ascertainment bias and other biases from randomized controlled trials could explain the long-term mortality…

Meeting NewsPerspective

Aspiration mechanical thrombectomy meets safety, efficacy endpoints for acute PE

November 11, 2019
LAS VEGAS — In the EXTRACT-PE trial, an aspiration mechanical thrombectomy device was safe and effective among patients with acute pulmonary…

Meeting News

Sirolimus-coated balloon benefit maintained at 2 years

November 7, 2019
LAS VEGAS — A sirolimus-coated balloon for treatment of peripheral artery disease was associated with positive outcomes at 2 years, according…

Meeting News

Peripheral stent beneficial in common femoral artery stenosis at 2 years

November 6, 2019
LAS VEGAS — A repuncturable vascular mimetic peripheral stent system was safe and effective at 2 years in patients with common femoral artery…

Meeting News

RANGER II SFA: Low-dose paclitaxel-coated balloon superior to PTA at 1 year

November 6, 2019
LAS VEGAS — A low-dose paclitaxel-coated balloon was superior to percutaneous transluminal angioplasty for treatment of femoropopliteal…

Meeting NewsPerspective

IMPERIAL: Peripheral DES similar in patency, different in TLR at 2 years

November 5, 2019
LAS VEGAS — A peripheral drug-eluting stent with a polymer coating conferred lower rates of target lesion revascularization compared with a…

Meeting NewsPerspective

Mortality not different at 5 years in patients treated with DES vs. controls

November 5, 2019
LAS VEGAS — There were no significant differences in mortality at 5 years between patients with peripheral artery disease assigned a…

Meeting News

New advances offer hope to patients with CLI

November 4, 2019
LAS VEGAS — While critical limb ischemia presents many challenges, numerous new technologies and techniques are being developed to help this…

Meeting News

More data needed on prevention of progression from claudication to CLI

November 4, 2019
LAS VEGAS — There has never been a randomized trial to determine what interventions may prevent progression from claudication to critical limb…


Mortality signal from paclitaxel-coated devices persists, but cause remains elusive

November 1, 2019
SAN FRANCISCO — Analyses continue to show a long-term mortality risk associated with paclitaxel-coated devices in patients with peripheral…

Siemens acquires robotic PCI technology for $1.1 billion

October 29, 2019
Siemens announced it has acquired Corindus Vascular Robotics, manufacturer of robotic-assisted PCI systems, for $1.1 billion. According to a press…

In the JournalsPerspective

Another study finds no evidence of increased long-term mortality with paclitaxel-coated devices

October 9, 2019
Patients who underwent endovascular revascularization with a paclitaxel-based drug-eluting device did not have an increased mortality risk over an…

FDA News

FDA designates recall of guide catheter as class 1

October 8, 2019
The FDA has designated Medtronic’s product recall of a guide catheter as a class 1 recall, the most serious kind. The recall affects 106,298…

Meeting News

AHA: More evidence needed for endovascular therapy for acute PE

October 7, 2019
Interventional devices for treatment of acute pulmonary embolism do not have a high level of evidence, and stakeholders must generate more evidence…

PAD Awareness Month: Five recent updates

September 27, 2019
In recognition of Peripheral Artery Disease Awareness Month in September, Healio has compiled a list of five recent updates on PAD. These updates…

FDA News

Sirolimus-eluting balloon given breakthrough device designation

September 18, 2019
Orchestra BioMed Inc., in partnership with Terumo Corporation, announced its sirolimus-eluting balloon for the treatment of below-the-knee peripheral…

In the Journals

Retrospective analysis finds no 5-year mortality risk tied to paclitaxel-coated devices

September 11, 2019
In a retrospective analysis of Japanese patients with peripheral artery disease treated with paclitaxel-coated devices or other devices…

Top intervention news of August: TAVR low-risk indications, FDA paclitaxel advisory and more

September 8, 2019
Healio compiled a list of the most-read cardiac and vascular intervention articles in August. This month, our readers were interested in the FDA…

In the JournalsPerspective

AHA: ‘Thorough evaluation of limb perfusion’ critical in CLI

August 12, 2019
The American Heart Association released a scientific statement outlining the options for perfusion assessment in patients with critical limb…